While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
(Nasdaq: DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2025 with total ...
Diabeloop receives US FDA 510(k) clearance for DBLG2, an automated insulin delivery algorithm: Grenoble, France Saturday, January 10, 2026, 10:00 Hrs [IST] Diabeloop, a global com ...
This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...
7d
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...
The Traitors spin-off host, Ed Gamble, had his whole world changed when he was just 13 years old. The youngster caught a ...
Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.
DexCom overview and recent share performance DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last ...
Zacks Investment Research on MSN
Is it the right time to add Insulet stock to your portfolio?
Insulet PODD is well-poised to grow in the coming quarters due to the strength of its Omnipod 5 platform. The company is strongly executing against its long-term priorities to drive penetration, ...
As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...
Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback